CN121287617B — 一种氟康唑滴耳液及其制备方法
Assigned to Boji Pharmaceutical Technology Co ltd · Expires 2026-04-17 · 0y expired
What this patent protects
本发明公开一种氟康唑滴耳液及其制备方法，属于滴耳液制剂技术领域，所述氟康唑滴耳液，按质量百分数计包括如下组分：氟康唑0.6%‑2.0%、丙二醇和/或二乙二醇单乙基醚8%‑20%、甘油或辛酸癸酸聚乙二醇甘油酯20%‑32%、羟丙甲纤维素0.1%‑1%、无水磷酸氢二钠0.05%‑0.2%、无水枸橼酸和水余量。本发明通过对氟康唑滴耳液处方的改进，增加了氟康唑的溶解度，制备的氟康唑滴耳液中氟康唑含量达到2%，且稳定性好，相比现有技术，本发明的氟康唑滴耳液对耳部真菌感染的治疗效果更佳。
USPTO Abstract
本发明公开一种氟康唑滴耳液及其制备方法，属于滴耳液制剂技术领域，所述氟康唑滴耳液，按质量百分数计包括如下组分：氟康唑0.6%‑2.0%、丙二醇和/或二乙二醇单乙基醚8%‑20%、甘油或辛酸癸酸聚乙二醇甘油酯20%‑32%、羟丙甲纤维素0.1%‑1%、无水磷酸氢二钠0.05%‑0.2%、无水枸橼酸和水余量。本发明通过对氟康唑滴耳液处方的改进，增加了氟康唑的溶解度，制备的氟康唑滴耳液中氟康唑含量达到2%，且稳定性好，相比现有技术，本发明的氟康唑滴耳液对耳部真菌感染的治疗效果更佳。
Drugs covered by this patent
- Cipro (Ciprofloxacin) · Alk Abello
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.